PEN - Penumbra, Inc.
| Previous Close | 140.84 |
| Open | 141.12 |
| Bid | 64.45 x 1000 |
| Ask | 0.00 x 800 |
| Day's Range | 136.01 - 142.62 |
| 52 Week Range | 82.55 - 167.35 |
| Volume | 203,874 |
| Avg. Volume | 330,966 |
| Market Cap | 4.709B |
| Beta (3Y Monthly) | 0.06 |
| PE Ratio (TTM) | 182.38 |
| EPS (TTM) | 0.75 |
| Earnings Date | Nov 5, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 168.00 |
- GlobeNewswire•19 hours ago
Analysis: Positioning to Benefit within Penumbra, Aetna, Littelfuse, IHS Markit, Credit Acceptance, and Insulet — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, Oct. 19, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
- Zacks•yesterday
Penumbra (PEN) Stock Moves -1.17%: What You Should Know
Penumbra (PEN) closed at $140.68 in the latest trading session, marking a -1.17% move from the prior day.
Markit•2 days agoSee what the IHS Markit Score report has to say about Penumbra Inc.
Short interest is low for PEN with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. The net inflows of $966 million over the last one-month into ETFs that hold PEN are not among the highest of the last year and have been slowing.
- PR Newswire•4 days ago
Penumbra, Inc. Schedules Third Quarter 2018 Earnings Release and Conference Call for November 5, 2018
ALAMEDA, Calif. , Oct. 15, 2018 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2018 after market close ...
- Zacks•9 days ago
Penumbra (PEN) Stock Moves -1.9%: What You Should Know
Penumbra (PEN) closed at $131 in the latest trading session, marking a -1.9% move from the prior day.
- Zacks•10 days ago
Top Stock Picks for the Week of October 8th
Two Technology Companies With Different Focus.
- Zacks•12 days ago
Accelerate Diagnostics (AXDX) Surges: Stock Moves 6% Higher
Accelerate Diagnostics (AXDX) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Markit•12 days agoSee what the IHS Markit Score report has to say about Penumbra Inc.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, growth of ETFs holding PEN is favorable, with net inflows of $6.49 billion.
- Zacks•16 days ago
Zacks Market Edge Highlights: Intuitive Surgical, BioTelemetry, Edwards Lifesciences, Penumbra and Vericel
Zacks Market Edge Highlights: Intuitive Surgical, BioTelemetry, Edwards Lifesciences, Penumbra and Vericel
American City Business Journals•16 days agoMedical device company signs 160,000-square-foot Roseville lease
Medical technology manufacturer Penumbra Inc. has signed a lease for an empty building formerly occupied by Hewlett Packard in Roseville.
- Zacks•25 days ago
Penumbra, Facebook, Softbank, Sony and Honda Motor highlighted as Zacks Bull and Bear of the Day
Penumbra, Facebook, Softbank, Sony and Honda Motor highlighted as Zacks Bull and Bear of the Day
- Zacks•25 days ago
Medical Instruments Stock Outlook: Long-Term Prospects Bright
Medical Instruments Stock Outlook: Long-Term Prospects Bright
- Zacks•29 days ago
Zacks.com highlights: G-III Apparel Group, HCA Healthcare, US Ecology, Penumbra and North American Construction Group
Zacks.com highlights: G-III Apparel Group, HCA Healthcare, US Ecology, Penumbra and North American Construction Group
Markit•last monthSee what the IHS Markit Score report has to say about Penumbra Inc.
Short interest is low for PEN with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. ETFs that hold PEN had net inflows of $2.75 billion over the last one-month.
Markit•last monthSee what the IHS Markit Score report has to say about Penumbra Inc.
Short interest is low for PEN with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, ETFs holding PEN are favorable, with net inflows of $3.11 billion.
- Zacks•last month
AngioDynamics (ANGO) to Acquire RadiaDyne, Boost Oncology
AngioDynamics' (ANGO) agreement to acquire RadiaDyne is expected to close by the end of September. The RadiaDyne acquisition will expand the Oncology segment.
- Zacks•last month
DENTSPLY Launches Azento, Improves Digital Implant Workflow
DENTSPLY's (XRAY) Azento is a unique dental platform that will help dentists select the best-fitting implant, optimal implant positioning and feasible healing environment.
- Zacks•last month
Here's Why You Should Invest in Penumbra (PEN) Stock Now
The market is quite upbeat about Penumbra's (PEN) recently-closed buyout of a controlling stake in MVI Health, aimed at capturing the great potential of virtual reality application.
- Zacks•last month
Allscripts' Sunrise Abstracting Selected by Wyckoff Heights
Allscripts' (MDRX) Sunrise Abstracting Solution gets picked by Wyckoff Heights Medical Center. The platform complements Allscripts Sunrise electronic health record unit.
- Zacks•last month
Here's Why You Should Hold On to DaVita (DVA) Stock Now
Strong prospects in the Kidney Care segment to drive DaVita (DVA) stock over the long haul.
- Simply Wall St.•last month
Shareholders Should Check If Insiders Own Shares In Penumbra Inc (NYSE:PEN)
Every investor in Penumbra Inc (NYSE:PEN) should be aware of the most powerful shareholder groups. Institutions will often hold stock in bigger companies, and we expect to see insiders owningRead More...
- Zacks•last month
Thermo Fisher to Acquire BD's Advanced Bioprocessing Unit
BD's (BDX) Advanced Bioprocessing business generates revenues worth $100 million annually. The unit will be integrated in the Thermo Fisher's (TMO) Life Sciences Solutions Segment.
- Markit•last month
See what the IHS Markit Score report has to say about Penumbra Inc.
Short interest is low for PEN with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. ETFs that hold PEN had net inflows of $2.72 billion over the last one-month.
- Zacks•last month
OPKO Health (OPK) Begins RAYALDEE Phase 2 Clinical Trial
OPKO Health's (OPK) consistent focus on enhancing the efficacy of its flagship RAYALDEE platform is likely to lend it a competitive edge in the MedTech space.
